China’s Sinovac May Start Philippine Vaccine Trials This Year
Vials of Sinovac’s CoronaVac SARS-CoV-2 vaccine are displayed at a media event in Beijing, China, on Sept. 24.
Photographer: Nicolas Bock/BloombergThis article is for subscribers only.
China’s Sinovac Biotech Ltd. may start Covid-19 vaccine trials in the Philippines before the end of the year, the chief of the Southeast Asian nation’s food and drug agency said.
Sinovac has passed the review of a vaccine experts panel to conduct Phase 3 clinical trials and is expected to submit as early as this week its application with the Philippines’ Food and Drug Administration, Eric Domingo, the agency’s director general, said in a virtual briefing Thursday. The approval process may take 21 days, he said.